| Name | Title | Contact Details |
|---|
LakeWood Health Center consists of the following four divisions: care center, clinic, hospital, and public health.. They service a population of 6,000 to 9,000 people, the number fluctuating with seasonal tourism activities. LakeWood is a federally designated Critical Access Hospital. As a Catholic non-profit organization, LakeWood Health Center is located in Baudette, Minnesota, and is owned and operated by Catholic Health Initiatives of Denver, Colorado. Our staff serve the social, health and welfare needs of the residents in Lake of the Woods County; contiguous counties, Koochiching, Beltrami, and Roseau; and neighboring Canada.
Swisher Memorial Hospital District's mission is to improve our quality of care and increase our services to meet the increasing healthcare demands for Swisher County and surrounding counties.
Eurogentec North America is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Monroe County Medical Center is a Tompkinsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.